The role of FDG-PET in Hodgkin lymphoma

about

Iodine-125 interstitial brachytherapy reduces tumor growth via Warburg effect inhibition in non-small cell lung cancer A549 ×enografts

P2860

Q57788714-4C8F0A20-56CE-4EF9-A8BB-2DA8350CF4B1

P2860

The role of FDG-PET in Hodgkin lymphoma

Item

http://www.wikidata.org/entity/Q41691698

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The role of FDG-PET in Hodgkin lymphoma

@en

type

Item

label

The role of FDG-PET in Hodgkin lymphoma

@en

prefLabel

The role of FDG-PET in Hodgkin lymphoma

@en

P1476

The role of FDG-PET in Hodgkin lymphoma

@en

P2093

Edyta Subocz

http://www.w3.org/2001/XMLSchema#string

Janusz Hałka

http://www.w3.org/2001/XMLSchema#string

Mirosław Dziuk

http://www.w3.org/2001/XMLSchema#string

P2860

Hodgkin lymphoma, version 2.2015.

Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group.

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale

18F-FDG PET, combined FDG-PET/CT and MRI for evaluation of bone marrow infiltration in staging of lymphoma: a systematic review and meta-analysis.

International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers.

Fluorine-18-fluorodeoxyglucose positron emission tomography in response assessment before high-dose chemotherapy for lymphoma: a systematic review and meta-analysis.

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.

Treatment of Hodgkin lymphoma: a 50-year perspective.

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

P304

104-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/WO.2017.68618

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28947879

http://www.w3.org/2001/XMLSchema#string

P932

5611499

http://www.w3.org/2001/XMLSchema#string

The role of FDG-PET in Hodgkin lymphoma

about

P2860

P2860

The role of FDG-PET in Hodgkin lymphoma

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932